Literature DB >> 11586469

Interactions between hepatic stellate cells and the immune system.

J J Maher1.   

Abstract

Stellate cells and immune cells are both active participants in the pathogenesis of liver disease. Interactions between these two populations are important determinants of disease outcome. Kupffer cells, neutrophils, and lymphocytes all have the potential to influence stellate cells. They produce a host of humoral mediators, including oxidants, nitric oxide, cytokines, eicosanoids, and proteinases, which can affect stellate cell proliferation, gene expression, and contractility. One important feature of stellate cell-immune cell interactions is that they are bidirectional. Not only do stellate cells receive signals from leukocytes, but they also elaborate signals that target leukocytes. Specifically, stellate cells can promote leukocyte chemotaxis and adherence, and they may also influence leukocyte activation by producing regulatory cytokines. Studies in culture provide an important background for understanding the effects of specific mediators on stellate cells and immune cells. Experiments in vivo offer an important adjunct, but often lead to confounding effects that limit interpretation. Both types of studies are required to develop a better understanding of the complex interplay between stellate cells and leukocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586469     DOI: 10.1055/s-2001-17555

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  44 in total

1.  Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells.

Authors:  Hendrik Reynaert; Krista Rombouts; Yutao Jia; Daniel Urbain; Nirjhar Chatterjee; Naoki Uyama; Albert Geerts
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction.

Authors:  Kalavathi Dasuri; Anhthao Nguyen; Le Zhang; Ok Sun Fernandez-Kim; Annadora J Bruce-Keller; Bradford A Blalock; Rafael De Cabo; Jeffrey N Keller
Journal:  Free Radic Res       Date:  2009-01

3.  Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.

Authors:  Elvira Olaso; Beatriz Arteta; Aitor Benedicto; Olatz Crende; Scott L Friedman
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

Review 4.  Recent advances in the pathogenesis and diagnosis of liver fibrosis.

Authors:  Natalie J Török
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 5.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

6.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.

Authors:  Guoping Jiang; Horng-Ren Yang; Lianfu Wang; Gary M Wildey; John Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.

Authors:  Ali Canbay; Maria Eugenia Guicciardi; Hajime Higuchi; Ariel Feldstein; Steven F Bronk; Robert Rydzewski; Makiko Taniai; Gregory J Gores
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 10.  Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.

Authors:  Konstantinos A Paschos; Ali W Majeed; Nigel C Bird
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.